<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-039766</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Tubulointerstitial nephritis associated with treatment with selective cox-2 inhibitors, celecoxib and rofecoxib</dc:title>
<dc:description xml:lang="en">The nephrotoxic effect of nonselective nonsteroidal anti-inflamatory drugs(NSAIDS) has been widely described. The main benefit of the Cox-2 inhibitors in relationto the NSAIDS is the production of a very similar analgesic effect, but with fewergastrointestinal side effects.However, their effects on renal function are little known asyet and their long-term safety is still pending definition. The use of selective Cox-2 inhibitorsas anti-inflamatory analgesic is becoming more and more common in our environment. We report two cases of tubulointersticial nephritis confirmed by renalbiopsy, associated with administration of the two Cox-2 inhibitors currently availableon the market, celecoxib and rofecoxib. In both cases, we were talking about elderlywomen, with deterioration of the general condition and acute renal failure. In the formercase, renal biopsy showed an acute tubulo-intersticial nephritis (TIN) so highly«variegated» in its histologic expression. In the second case, was associated withstrong indications of chronicity. Treatment with steroid was initiated in both patientsand improvement of renal function was observed</dc:description>
<dc:creator>Mampaso, F</dc:creator>
<dc:creator>Ortiz, M</dc:creator>
<dc:creator>Fernández, M. J</dc:creator>
<dc:creator>Mon, C</dc:creator>
<dc:creator>Álvarez Ude, F</dc:creator>
<dc:creator>Sánchez, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El efecto nefrotóxico de los inhibidores selectivos de la Cox-2 es poco conocido. Elprincipal beneficio de los inhibidores de la Cox-2 con respecto a los AINES clásicos esla producción de un efecto analgésico muy similar, pero con menos efectos secundariosa nivel gastrointestinal. Sin embargo, sus efectos sobre la función renal son pococonocidos todavía y su seguridad a largo plazo está todavía por definir. El uso de inhibidoresselectivos de la Cox-2 como analgésicos y antiinflamatorios es cada vez másfrecuente en nuestro medio. Nosotros referimos dos casos de nefritis tubulointersticialconfirmadas por biopsia renal, asociadas a la toma de los dos inhibidores de la Cox-2comercializados en la actualidad, celecoxib y rofecoxib. Ambos se presentaron enmujeres de edad avanzada, cursaron con importante afectación del estado general yfracaso renal agudo. En el primer caso, la biopsia renal mostró una nefritis tubulointersticialaguda (NTI) muy abigarrada en su expresión histológica. En el segundo, seasoció con importantes datos de cronicidad. Los dos casos se trataron con esteroidescon buena evolución de la función renal</dc:description>
<dc:source>Nefrologia;25(1): 39-43, ene. 2005. ilus</dc:source>
<dc:identifier>ibc-039766</dc:identifier>
<dc:title xml:lang="es">Nefritis tubulointersticial asociada al tratamiento con inhibidores de la Cox-2, celecoxib y rofecoxib</dc:title>
<dc:subject>^d29622</dc:subject>
<dc:subject>^d9588^s22057</dc:subject>
<dc:subject>^d13837^s22020</dc:subject>
<dc:subject>^d9588^s22036</dc:subject>
<dc:subject>^d13838^s22020</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d9588^s22053</dc:subject>
<dc:subject>^d12157^s22020</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d30165^s22020</dc:subject>
<dc:subject>^d7960^s22020</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:type>article</dc:type>
<dc:date>200501</dc:date>
</metadata>
</record>
</ibecs-document>
